The tumor marker test for the pancreas is a test used to detect the presence of certain proteins or substances that may indicate the presence of pancreatic cancer. These markers are produced by the cells of the pancreas and can be detected in the blood, urine, or other body fluids. The test can be used to help diagnose and monitor pancreatic cancer, as well as to determine the effectiveness of treatments.
What Does the Test Measure?
The tumor marker test measures the levels of certain proteins (markers) in the body that are associated with pancreatic cancer. The most common markers used in the test are carcinoembryonic antigen (CEA) and CA 19-9. These markers are usually found in higher levels in people with pancreatic cancer, although they can also be present in other types of cancer or other health conditions.
How Is the Test Performed?
The tumor marker test is usually performed as a simple blood test. The doctor or technician will take a sample of blood from the patient and send it to a laboratory for analysis. The results of the test will then be used to determine the levels of the markers in the patient's body.
What Are the Results of the Test?
The results of the test will provide information about the levels of the markers in the patient's body. If the levels are higher than normal, it could indicate the presence of pancreatic cancer. However, it is important to note that the presence of these markers does not necessarily mean that the person has pancreatic cancer. Other conditions, such as inflammation or infection, can also cause elevated levels of these markers.
What Are the Benefits of the Test?
The tumor marker test can help to diagnose and monitor pancreatic cancer. It can also be used to determine the effectiveness of treatments. The test is relatively inexpensive and can be done quickly and accurately.
